Low-Dose Phase 3 Sucrase Inhibitor L-Arabinose and Chromium GlycoProtein Matrix Supplements
1 products up to 550 mg
1 supplements contain low-dose Phase 3 Sucrase Inhibitor L-Arabinose and Chromium GlycoProtein Matrix (up to 550 mg).
Low Dose (1)High Dose (1)
Low-Dose Products (sorted by dosage)
| Product | Brand | Dosage | % DV |
|---|---|---|---|
| Natural Glucose | Life Extension | 550 mg | — |
Frequently Asked Questions
What is considered low-dose Phase 3 Sucrase Inhibitor L-Arabinose and Chromium GlycoProtein Matrix?
Based on 3 products in the NIH DSLD database, low-dose Phase 3 Sucrase Inhibitor L-Arabinose and Chromium GlycoProtein Matrix supplements contain up to 550 mg.
Who might benefit from low-dose Phase 3 Sucrase Inhibitor L-Arabinose and Chromium GlycoProtein Matrix?
Consult a healthcare professional to determine the appropriate Phase 3 Sucrase Inhibitor L-Arabinose and Chromium GlycoProtein Matrix dosage for your needs. This site presents supplement label data only.